ApprovalTrail

Approval · Notice of Compliance 7172 · 1995

SUROLAN DROPS: Notice of Compliance 7172

Issued February 3, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7172
Date
February 3, 1995
Company
Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
To provide a new indication
Therapeutic class
Antifungal, antibacterial, anti-inflammatory

Products in this notice

BrandDINStatus today
SUROLAN DROPSNot yet assigned—

Medicinal ingredients